{
    "Trade/Device Name(s)": [
        "IVD-GE02"
    ],
    "Submitter Information": "Sphere Medical Ltd.",
    "510(k) Number": "K101947",
    "Predicate Device Reference 510(k) Number(s)": [
        "K934907"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHL",
        "CEM",
        "CGA",
        "JIX"
    ],
    "Summary Letter Date": "February 4, 2011",
    "Summary Letter Received Date": "February 7, 2011",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1120",
        "21CFR862.1600",
        "21CFR862.1345",
        "21CFR862.1150"
    ],
    "Regulation Name(s)": [
        "Blood Gases (pCO2, pO2) and Blood pH Test System",
        "Electrode, Ion Specific Potassium",
        "Glucose oxidase, Glucose",
        "Calibrators"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "pH",
        "pCO2",
        "pO2",
        "Potassium",
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole blood"
    ],
    "Specimen Container(s)": [
        "Heparinized vacutainer"
    ],
    "Instrument(s)/Platform(s)": [
        "IVD-GE02 system",
        "Dedicated combined PC and monitor",
        "Disposable cartridge"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical",
        "Potentiometric",
        "Amperometric"
    ],
    "Methodologies": [
        "Multi-analyte chip",
        "Sensor array",
        "Calibration solutions"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Cartridge",
        "Calibration solution",
        "Printer",
        "Sensor chip",
        "Waste container"
    ],
    "Document Summary": "FDA 510(k) summary for IVD-GE02 modular blood analyzer measuring pH, blood gases, potassium, and glucose in whole blood using electrochemical sensors",
    "Indications for Use Summary": "Quantitative measurement of pH, pCO2, pO2, potassium, and glucose in whole blood samples in a clinical laboratory; used in diagnosis and treatment of acid-base disturbances, electrolyte imbalance, and carbohydrate metabolism disorders",
    "fda_folder": "Clinical Chemistry"
}